Usual and Unusual Agranulocytosis During Neuroleptic Therapy
Abstract
Agranulocytosis, an uncommon side effect of phenothiazine treatment, usually occurs within the first three months of such treatment and remits after the substitution of another neuroleptic. The authors report one patient in whom the illness took its usual course and two in whom it did not. Of these two, one patient demonstrated agranulocytosis only after years of phenothiazine therapy and the other showed agranulocytic reactions to various neuroleptics.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).